JESSICA BRIDGFORTH: Open Payments
NPI 1497305262 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 101 payments from 12 companies in 2025. Trend: 2023 $1,856 · 2024 $1,524 · 2025 $1,363
Food & beverage: $1,363
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 34 | $341 |
| Janssen Biotech, Inc. | 19 | $271 |
| ABBVIE INC. | 21 | $238 |
| Ardelyx, Inc. | 12 | $229 |
| GENZYME CORPORATION | 5 | $106 |
| QOL Medical, LLC | 3 | $58 |
| PFIZER INC. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $16 |
| Gilead Sciences, Inc. | 1 | $16 |
Products named: VOQUEZNA, TREMFYA, IBSRELA, RINVOQ, MAVYRET, Sucraid, SKYRIZI, VELSIPITY.
Industry payments across KY — which companies pay providers there.
